| abstract |
A dosage form comprising a plurality of particles having interior pores and a liquid, active agent formulation in the pores, the particles being compactab le and adapted to retain substantially all of the liquid active agent formulati on within the pores during the compacting process, is described. The dosage for ms may be in the forms of unitary oral forms for immediate release of active agent, prolonged delivery forms, or controlled delivery forms. All forms involve certain absorbent materials having prescribed characteristics, particularly spray dried calcium hydrogen phosphate and magnesium aluminometasilicate. |